» Articles » PMID: 34213709

Association Between [Ga]NODAGA-RGDyK Uptake and Dynamics of Angiogenesis in a Human Cell-based 3D Model

Overview
Journal Mol Biol Rep
Specialty Molecular Biology
Date 2021 Jul 2
PMID 34213709
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Radiolabeled RGD peptides targeting expression of αβ integrin have been applied to in vivo imaging of angiogenesis. However, there is a need for more information on the quantitative relationships between RGD peptide uptake and the dynamics of angiogenesis. In this study, we sought to measure the binding of [Ga]NODAGA-RGDyK to αβ integrin in a human cell-based three-dimensional (3D) in vitro model of angiogenesis, and to compare the level of binding with the amount of angiogenesis. Experiments were conducted using a human cell-based 3D model of angiogenesis consisting of co-culture of human adipose stem cells (hASCs) and of human umbilical vein endothelial cells (HUVECs). Angiogenesis was induced with four concentrations (25%, 50%, 75%, and 100%) of growth factor cocktail resulting in a gradual increase in the density of the tubule network. Cultures were incubated with [Ga]NODAGA-RGDyK for 90 min at 37 °C, and binding of radioactivity was measured by gamma counting and digital autoradiography. The results revealed that tracer binding increased gradually with neovasculature density. In comparison with vessels induced with a growth factor concentration of 25%, the uptake of [Ga]NODAGA-RGDyK was higher at concentrations of 75% and 100%, and correlated with the amount of neovasculature, as determined by visual evaluation of histological staining. Uptake of [Ga]NODAGA-RGDyK closely reflected the amount of angiogenesis in an in vitro 3D model of angiogenesis. These results support further evaluation of RGD-based approaches for targeted imaging of angiogenesis.

Citing Articles

Exploring the landscape of current in vitro and in vivo models and their relevance for targeted radionuclide theranostics.

Bokhout L, Campeiro J, Dalm S Eur J Nucl Med Mol Imaging. 2025; .

PMID: 40016527 DOI: 10.1007/s00259-025-07123-3.


Cell-Seeded Biomaterial Scaffolds: The Urgent Need for Unanswered Accelerated Angiogenesis.

Shokrani H, Shokrani A, Sajadi S, Seidi F, Hamed Mashhadzadeh A, Rabiee N Int J Nanomedicine. 2022; 17:1035-1068.

PMID: 35309965 PMC: 8927652. DOI: 10.2147/IJN.S353062.

References
1.
Haubner R, Maschauer S, Einsiedel J, Eder I, Rangger C, Gmeiner P . H-CRRETAWAC-OH, a lead structure for the development of radiotracer targeting integrin α5β1?. Biomed Res Int. 2014; 2014:243185. PMC: 4211326. DOI: 10.1155/2014/243185. View

2.
Sun Y, Zeng Y, Zhu Y, Feng F, Xu W, Wu C . Application of (68)Ga-PRGD2 PET/CT for αvβ3-integrin imaging of myocardial infarction and stroke. Theranostics. 2014; 4(8):778-86. PMC: 4063976. DOI: 10.7150/thno.8809. View

3.
Dobrucki L, Tsutsumi Y, Kalinowski L, Dean J, Gavin M, Sen S . Analysis of angiogenesis induced by local IGF-1 expression after myocardial infarction using microSPECT-CT imaging. J Mol Cell Cardiol. 2009; 48(6):1071-9. PMC: 2866767. DOI: 10.1016/j.yjmcc.2009.10.008. View

4.
Jenkins W, Vesey A, Stirrat C, Connell M, Lucatelli C, Neale A . Cardiac αβ integrin expression following acute myocardial infarction in humans. Heart. 2016; 103(8):607-615. PMC: 5566089. DOI: 10.1136/heartjnl-2016-310115. View

5.
Beer A, Schwaiger M . Imaging of integrin alphavbeta3 expression. Cancer Metastasis Rev. 2008; 27(4):631-44. DOI: 10.1007/s10555-008-9158-3. View